202 related articles for article (PubMed ID: 3987714)
1. Oral BVDU treatment of varicella and zoster in children with cancer.
Benoit Y; Laureys G; Delbeke MJ; De Clercq E
Eur J Pediatr; 1985 Jan; 143(3):198-202. PubMed ID: 3987714
[TBL] [Abstract][Full Text] [Related]
2. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
Wildiers J; De Clercq E
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):471-6. PubMed ID: 6539202
[TBL] [Abstract][Full Text] [Related]
3. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
de Clercq E; Degreef H; Wildiers J; de Jonge G; Drochmans A; Descamps J; de Somer P
Br Med J; 1980 Nov; 281(6249):1178. PubMed ID: 7427624
[No Abstract] [Full Text] [Related]
4. [5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
Wutzler P; Wutke K; Bärwolff D; Reefschläger J
Z Gesamte Inn Med; 1988 Dec; 43(23):677-80. PubMed ID: 2854331
[TBL] [Abstract][Full Text] [Related]
5. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
6. Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.
Tricot G; De Clercq E; Boogaerts MA; Verwilghen RL
J Med Virol; 1986 Jan; 18(1):11-20. PubMed ID: 3511181
[TBL] [Abstract][Full Text] [Related]
7. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
[TBL] [Abstract][Full Text] [Related]
8. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Shigeta S; Yokota T; De Clercq E
Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264
[No Abstract] [Full Text] [Related]
9. [Antiviral chemotherapy].
Eggers HJ
Monatsschr Kinderheilkd; 1986 Mar; 134(3):122-9. PubMed ID: 3010086
[TBL] [Abstract][Full Text] [Related]
10. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin.
Heidl M; Scholz H; Dörffel W; Hermann J
Infection; 1991; 19(6):401-5. PubMed ID: 1816110
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir administered perorally in immunocompromised children with varicella-zoster infections.
Novelli VM; Marshall WC; Yeo J; McKendrick GD
J Infect Dis; 1984 Mar; 149(3):478. PubMed ID: 6715905
[No Abstract] [Full Text] [Related]
13. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Sim IS
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
De Clercq E; Descamps J; Ogata M; Shigeta S
Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
17. Brivudin (bromovinyl deoxyuridine).
Keam SJ; Chapman TM; Figgitt DP
Drugs; 2004; 64(18):2091-7; discussion 2098-9. PubMed ID: 15341504
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus.
Whitley RJ
Pediatr Infect Dis J; 1989 Sep; 8(9):584-5. PubMed ID: 2552389
[No Abstract] [Full Text] [Related]
19. Short-time and low-dose intravenous acyclovir therapy in varicella zoster infections with malignant disease in children receiving combined chemotherapy.
Sarialioğlu F; Buyukpamukcu M; Cevik N; Kutluk MT; Akyol H; Kansu E
Pediatr Hematol Oncol; 1986; 3(3):267-71. PubMed ID: 3153239
[TBL] [Abstract][Full Text] [Related]
20. Varicella vaccination in children after bone marrow transplantation.
Sauerbrei A; Prager J; Hengst U; Zintl F; Wutzler P
Bone Marrow Transplant; 1997 Sep; 20(5):381-3. PubMed ID: 9339753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
